LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Search

Bio-Rad Laboratories Inc

Gesloten

SectorGezondheidszorg

288.16 0.54

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

285.82

Max

288.63

Belangrijke statistieken

By Trading Economics

Inkomsten

-731M

-11M

Verkoop

-101M

592M

K/W

Sectorgemiddelde

46.97

49.701

EPS

1.89

Winstmarge

-1.858

Werknemers

7,450

EBITDA

-792M

-678M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+2.96% upside

Dividenden

By Dow Jones

Volgende Winsten

30 jul 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-216M

7.5B

Vorige openingsprijs

287.62

Vorige sluitingsprijs

288.16

Nieuwssentiment

By Acuity

50%

50%

151 / 345 Rangschikking in Healthcare

Bio-Rad Laboratories Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 jul 2025, 23:56 UTC

Populaire aandelen

Stocks to Watch: Amazon, Bio-Rad, Coinbase, Mercer

Peer Vergelijking

Prijswijziging

Bio-Rad Laboratories Inc Prognose

Koersdoel

By TipRanks

2.96% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 296.25 USD  2.96%

Hoogste 320 USD

Laagste 275 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bio-Rad Laboratories Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

4 ratings

1

Buy

3

Hold

0

Sell

Sentiment

By Acuity

151 / 345 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
help-icon Live chat